Internal Medicine News - Zetia
Monday, December 29th, 2008 (ezetimibe, Merck and Schering-Plough)
A cholesterol absorption inhibitor for use as an adjunct to diet for reducing elevated total cholesterol, LDL cholesterol, and apo B levels in patients with primary (heterozygous familial and nonfamilial) hypercholesterolemia, either alone or with an HMG-CoA reductase inhibitor. The first d…
